C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
11/2006
11/22/2006	CN1867542A Process of preparing O-carbamoyl compounds in the presence of active amine group
11/22/2006	CN1865228A N alpha-Boc-N beta-Cbz-L-2,3 diaminopropionic acid derivative synthesis method
11/21/2006	US7138547 Antitumoral compounds
11/21/2006	CA2120619C Novel potent inducers of terminal differentiation and methods of use thereof
11/16/2006	WO2006121095A1 Substituted acrylamide derivative and pharmaceutical composition comprising the same
11/16/2006	US20060258886 Alpha, omega-difuctional aldaramides
11/16/2006	US20060257479 Long-acting molecules in sustained release formulations
11/16/2006	US20060257354 Ethylene copolymer waxes containing amino groups and use thereof
11/16/2006	CA2608248A1 Soluble epoxide hydrolase inhibitors and methods of using same
11/16/2006	CA2607298A1 Antineoplastic compounds and pharmaceutical compositions thereof
11/15/2006	EP1412383B1 Peptide conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri)
11/15/2006	CN1863920A Conjugation of peptides
11/15/2006	CN1863769A Process for producing aminopyrrolidine derivative and intermediate compound
11/15/2006	CN1861631A Coupling compound of tetracycline, preparation process and application thereof
11/15/2006	CN1284772C Benzamide kind histon deacetylase inhibiting agent having dissociation and antibred activity and its medicinal preparation
11/14/2006	US7135586 Biphenylcarboxamides useful as lipid lowering agents
11/14/2006	US7135502 Colchinol derivatives as vascular damaging agents
11/14/2006	US7135483 Substituted heterocyclic compounds for treating multidrug resistance
11/14/2006	CA2156432C New derivatives of glutamic and aspartic acids, a method of preparing them, and their use as drugs for enhancing memory and learning
11/09/2006	WO2006025978A3 Non-antibiotic intervention of chlamydial infection
11/09/2006	DE10361140B4 Verfahren zur Herstellung von dendritischen Trimesinsäuretriamiden, dabei verwendete Diethylentriaminderivate und Verwendung der Diethylentriaminderivate A process for the preparation of dendritic Trimesinsäuretriamiden, Diethylentriaminderivate used therein and using the Diethylentriaminderivate
11/08/2006	EP1294691B1 Serine protease inhibitors
11/08/2006	EP0993437B1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors
11/08/2006	CN1860097A Amide type carboxamide derivative
11/08/2006	CN1283656C C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
11/08/2006	CN1283622C Cyclohexyl (alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
11/07/2006	US7132569 N,N-disubstituted-2,7-dialkyl-8-aryl-4-octeneamides and the intermediates: N,N-disubstituted-5-halo- or azido-2-alkyl-4-pentenamides and 2-alkyl-5-(4-aryl-2-halo- or azido-3-alkylbutylbutyrolactones that may be used to prepare them
11/07/2006	US7132568 beta-amino amides; treating degenerative dementias characterized by beta-amyloid deposits in the brain, especially Alzheimer's Disease
11/07/2006	US7132559 Thermal and chemical denaturing resistance; tailored protein cores
11/07/2006	US7132537 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
11/07/2006	US7132457 Adamantane derivatives
11/07/2006	US7132445 Antiinflammatory agents; anticancer agents; analgesics; antiarthritic agents; inflammatory bowel disorders; respiratory system disorders
11/07/2006	US7132420 Aspartic protease inhibitors
11/02/2006	WO2006115194A1 Method of separating and collecting optically active amino acid amide
11/02/2006	WO2006114262A1 Acetylene derivatives
11/02/2006	WO2006093823A9 2- [ isoquinolin-s - carbonyl ) amino] -propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis
11/02/2006	US20060247289 Certain chemical entities, compositions, and methods
11/02/2006	US20060247274 N,N-bis(3-Phenoxycinnamyl)Glu(O-t-Bu)-OMe; demonstrate competitive binding with the natural ligand; ease administration, cost less and facilitate patient compliance; USEFUL IN TREATMENT OF DISEASES OR CONDITIONS ASSOCIATED WITH ERYTHROPOIETIN RECEPTOR
11/02/2006	US20060246482 Linker molecules for selective metallisation of nucleic acids and their uses
11/02/2006	EP1717226A1 2,7-substituted 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octan amide derivatives as renin inhibitors for the treatment of hypertension
11/02/2006	EP1716101A1 Aromatic a-ring derivatives of tetracycline compounds
11/02/2006	EP1401801B1 Selective androgen receptor modulators and methods of use thereof
11/02/2006	EP1339685B1 Biphenylcarboxamides useful as lipid lowering agents
11/02/2006	EP1219596B1 Salicylamide derivatives
11/02/2006	CA2605265A1 Acetylene derivatives
11/01/2006	CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/01/2006	CN1854122A Blood pool agents for nuclear magnetic resonance diagnostics
11/01/2006	CN1282641C Novel naphthylsulfonic acids and related compounds as glucose uptake agonists
11/01/2006	CN1282640C N-arylphenylacetamide derivatives and medicinal compositions containing same
10/2006
10/26/2006	WO2003006628A3 Nad synthetase inhibitors and uses thereof
10/26/2006	US20060241179 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
10/26/2006	US20060241129 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
10/25/2006	EP1714958A1 Amide derivatives, process for production of the same, and method for application thereof as insecticide
10/25/2006	EP1713823A2 Hcv ns-3 serine protease inhibitors
10/25/2006	EP1713822A2 Hcv ns-3 serine protease inhibitors
10/25/2006	EP1713757A2 Hydroaminomethylation of olefins
10/25/2006	EP1713510A2 Growth factor-binding compounds attached to a calixarene
10/25/2006	EP1713465A2 Compounds and compositions as lxr modulators
10/25/2006	EP1265849B1 Compounds and methods to treat alzheimer's disease
10/25/2006	EP0983227B8 Preparation of tri-iodo benzene compounds
10/25/2006	CN1852890A Abiotic heparin antagonists
10/25/2006	CN1281274C 6-fluorobicyclo [3.1.0] hexane derivatives
10/24/2006	US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents
10/24/2006	US7126009 Palladium catalyzed indolization of 2-bromo or chloroanilines
10/24/2006	US7126001 Antiproliferative agents; antitumor agents
10/24/2006	US7125910 Compounds and compositions for delivering active agents
10/24/2006	US7125875 Cyclic protein tyrosine kinase inhibitors
10/24/2006	US7125871 Excitatory amino acid receptor modulators
10/24/2006	US7125869 Drugs for cosmetics for treatment of cardiovadcular disorders, receptors, immunology or lipid metabolism
10/24/2006	US7125852 Geranyl compounds
10/24/2006	CA2363690C Hsv primase inhibitors
10/24/2006	CA2300603C New compounds of the benzylaminodiacetamide family, formulations including them, preparation process and uses
10/24/2006	CA2262451C Boronic compound complexing reagents and complexes
10/19/2006	WO2006110477A2 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus
10/19/2006	WO2006090265A3 Processes for the preparation of levetiracetam, its intermediate and the use of levetiracetam in pharmaceutical compositions
10/19/2006	US20060235239 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
10/19/2006	US20060235081 1-(2-hydroxyphenyl)-2,6-dione-3-ene-4-hydroxy-heptane; suppressing excess immunoglobulin (IgE) levels, eliminating side effects associated with tetracyclines; asthma, allergies, inflammatory conditions, or other diseases where IgE is pathogenic
10/19/2006	US20060235074 Matrix metalloproteinase inhibitors
10/19/2006	US20060235073 Diamino-functional chalcones
10/19/2006	US20060235035 Novel methoxybenzamibe compounds for use in mch receptor related disorders
10/19/2006	US20060234988 7-N-substituted phenyl tetracycline compounds
10/18/2006	EP1712548A2 5-amino-4-hydroxy-7-(pyridinylmethyl)-alkanamide derivatives and related compounds as renin inhibitors for the treatment of hypertension
10/18/2006	EP1711481A2 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
10/18/2006	CN1849117A Entry inhibitors of the HIV virus
10/18/2006	CN1280261C Improved process for synthesizing L-theanine
10/17/2006	US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc
10/17/2006	US7122547 Anthranilic acid amides and the use thereof as medicaments
10/17/2006	CA2318527C Inhibitors of .alpha.4 mediated cell adhesion
10/12/2006	WO2006107098A1 Glycerol ester derivative having metal chelate structure
10/12/2006	WO2006106727A1 Benzyloxypropylamine derivative
10/12/2006	US20060229470 Calcium receptor-active molecules
10/12/2006	US20060229282 New analogues for tetracycline-resistant organisms; Bactericides, bacteriostats; bacterial infections specially against Escherichia coli, Staphylococcus aureus, and Enterococcus faecalis; cancer, diabetes; 7-(2-pyridinyl)doxycycline
10/12/2006	US20060228737 contacting the sample with a bifunctional material containing an amino group and a carboxyl group at a first pH to bind the nucleic acid to the bifunctional material, being positively charged at the first pH; releasing the nucleic acid at a second pH which is higher than the first pH; high efficiency
10/12/2006	US20060228322 Method for improving conversion rate of oil soluble unsaturated lipids into water-soluble lipids
10/12/2006	CA2603030A1 Benzyloxypropylamine derivative
10/11/2006	EP1710238A1 Benzophenones as inhibitors of reverse transcriptase
10/11/2006	EP1709029A2 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
10/11/2006	EP1708698A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
10/11/2006	CN1845897A 取代的四环素化合物 Substituted tetracycline compound
10/10/2006	US7119085 Inhibit amyloid protein deposits

1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 162